These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39179990)

  • 1. Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019.
    Rotsaert A; Smekens T; Jaminé D; Di Zinno T; Deblonde J; Lambert ML; Florence E; Reyniers T; Vanhamel J; Lucet C; van der Loeff MS; Hensen B; Vuylsteke B
    BMC Public Health; 2024 Aug; 24(1):2296. PubMed ID: 39179990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis.
    Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P
    JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
    Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
    Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study.
    Hechter RC; Bruxvoort KJ; Zhou H; Towner WJ; Contreras R; Schumacher CM; Grant DL; Jones J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):1-8. PubMed ID: 35499561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022.
    von Schreeb S; Pedersen SK; Christensen H; Jørgsensen KM; Harritshøj LH; Hertz FB; Ahlström MG; Lebech AM; Lunding S; Nielsen LN; Gerstoft J; Kronborg G; Engsig FN
    Euro Surveill; 2024 Mar; 29(13):. PubMed ID: 38551099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study.
    Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V;
    Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
    Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
    Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany.
    Valbert F; Schmidt D; Kollan C; Dröge P; Klein M; Schneider U; Friebe M; Wasem J; Neumann A
    Arch Sex Behav; 2024 Oct; 53(9):3663-3672. PubMed ID: 39107531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK.
    O'Halloran C; Croxford S; Mohammed H; Gill ON; Hughes G; Fifer H; Allen H; Owen G; Nutland W; Delpech V; Saunders JM
    Sex Transm Infect; 2021 Sep; 97(6):429-433. PubMed ID: 33082235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.